Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2005-04-05
2005-04-05
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S468000, C424S484000, C424S488000, C424S489000
Reexamination Certificate
active
06875446
ABSTRACT:
A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% w/w of the formulation.
REFERENCES:
patent: 5430023 (1995-07-01), Gesellchen et al.
patent: 5510369 (1996-04-01), Lumma et al.
patent: 5532267 (1996-07-01), Nakayama
patent: 5714485 (1998-02-01), Lumma et al.
patent: 5798377 (1998-08-01), Lumma et al.
patent: 5840769 (1998-11-01), Kolter et al.
patent: 2239931 (2000-01-01), None
patent: 0255002 (1988-02-01), None
patent: 0643073 (1995-03-01), None
patent: 0803251 (1997-10-01), None
patent: 1044680 (2000-10-01), None
patent: 9305069 (1993-03-01), None
patent: 9311152 (1993-06-01), None
patent: 9429330 (1994-12-01), None
patent: 9601622 (1996-01-01), None
patent: 9717947 (1997-05-01), None
patent: 9722340 (1997-06-01), None
patent: 9723499 (1997-07-01), None
patent: 9813029 (1998-04-01), None
patent: 9961002 (1999-12-01), None
patent: 0001368 (2000-01-01), None
patent: 0009090 (2000-02-01), None
patent: 0018447 (2000-04-01), None
patent: 0059479 (2000-10-01), None
patent: 0059481 (2000-10-01), None
Lachman, L. et al. The Theory and Practice of Industrial Pharmacy. Lca & Febiger Publ.,3rdEd.pp. 343-345, 1986.
Sandell, E. Galenic Pharmaceuticals, 2ndEd. Stockholm, Sweden, pp. 288-290, 1967.
Composition of Seloken metoprolol tartrate tablets, manufactured by Hässle and approved in Sweden in 1975.
Composition of felodipine immediate-release tablets, manufactured by Hässle and registered in Australia in 1987.
Composition of Seloken metoprolol tartrate tablets, manufactured by Hässle and registered in Sweeden in 1975.
Forsman Sigbrit
Karlsson Christer
Karlsson Magnus
AstraZeneca AB
Fubara Blessing
Page Thurman K.
White & Case LLP
LandOfFree
Method for prophylaxis and/or treatment of thromboembolism does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for prophylaxis and/or treatment of thromboembolism, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for prophylaxis and/or treatment of thromboembolism will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3391285